These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28099462)

  • 1. Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo.
    Serrano-Pozo A; Sánchez-García MA; Heras-Garvín A; March-Díaz R; Navarro V; Vizuete M; López-Barneo J; Vitorica J; Pascual A
    PLoS One; 2017; 12(1):e0170345. PubMed ID: 28099462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.
    Zhang X; Zhou K; Wang R; Cui J; Lipton SA; Liao FF; Xu H; Zhang YW
    J Biol Chem; 2007 Apr; 282(15):10873-80. PubMed ID: 17303576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-β Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAβPPα.
    Owens L; Bracewell J; Benedetto A; Dawson N; Gaffney C; Parkin E
    J Alzheimers Dis; 2022; 86(3):1201-1220. PubMed ID: 35180123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
    Devi L; Ohno M
    Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice.
    Shiota S; Takekawa H; Matsumoto SE; Takeda K; Nurwidya F; Yoshioka Y; Takahashi F; Hattori N; Tabira T; Mochizuki H; Takahashi K
    J Alzheimers Dis; 2013; 37(2):325-33. PubMed ID: 23948880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
    Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
    J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitate Increases β-site AβPP-Cleavage Enzyme 1 Activity and Amyloid-β Genesis by Evoking Endoplasmic Reticulum Stress and Subsequent C/EBP Homologous Protein Activation.
    Marwarha G; Rostad S; Lilek J; Kleinjan M; Schommer J; Ghribi O
    J Alzheimers Dis; 2017; 57(3):907-925. PubMed ID: 28304295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression.
    Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G
    J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
    Hook G; Hook V; Kindy M
    J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auraptene increases the production of amyloid-β via c-Jun N-terminal kinase-dependent activation of γ-secretase.
    Jung CG; Uhm KO; Horike H; Kim MJ; Misumi S; Ishida A; Ueda Y; Choi EK; Kim YS; Michikawa M; Hida H
    J Alzheimers Dis; 2015; 43(4):1215-28. PubMed ID: 25147119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K/Akt pathway in the brain of APP/PS1 transgenic mouse.
    He XL; Yan N; Chen XS; Qi YW; Yan Y; Cai Z
    Pharmacol Rep; 2016 Oct; 68(5):975-82. PubMed ID: 27372924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway.
    Guglielmotto M; Monteleone D; Giliberto L; Fornaro M; Borghi R; Tamagno E; Tabaton M
    J Alzheimers Dis; 2011; 27(4):871-83. PubMed ID: 21897006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.
    Velliquette RA; O'Connor T; Vassar R
    J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid secretases and beta-amloid degrading enzyme expression in lens.
    Li G; Percontino L; Sun Q; Qazi AS; Frederikse PH
    Mol Vis; 2003 May; 9():179-83. PubMed ID: 12740567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.